From Generics to Biologics: Semaglutide Reshapes Pharma Manufacturing in India
The recent developments around semaglutide in India—triggered by patent expiry and rapid domestic entry—are poised to significantly reshape the country’s pharmaceutical manufacturing landscape.
Pharma Manufacturing In India | 23/03/2026 | By Darshana | 174
A New Year, A New Chapter for Pharma Manufacturing in India
As India steps into a new year, the pharmaceutical manufacturing sector stands at a defining crossroads. Over the past few years, Indian pharma has moved far beyond its traditional identity as the “pharmacy of the world” for generics.
Pharma Manufacturing In India | 01/01/2026 | By Darshana | 200
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy